文献速递产科母胎医学

宫颈阴道生殖支原体检测与早产及低出生体重相关:系统综述与多变量荟萃分析

Cervicovaginal detection of genital mycoplasmas is associated with preterm birth and low birth weight: a systematic review and multivariate meta-analysis of adverse pregnancy outcomes.
PubMed 文献 · Am J Obstet Gynecol · 2026-03-25

该系统综述与荟萃分析纳入156项观察性研究,评估宫颈阴道生殖支原体检测与不良妊娠结局的关联。宫颈阴道样本中微小脲原体检出与早产(OR 1.63,95%CI 1.36-1.96)及低出生体重(OR 1.56,95%CI 1.33-1.83)显著相关,人型支原体亦与早产(aOR 1.75,95%CI 1.21-2.53)和低出生体重(OR 1.81,95%CI 1.51-2.16)相关。因观察性数据及残余混杂,不推荐常规筛查或治疗。

要点

  • 宫颈阴道微小脲原体检出与早产和低出生体重显著相关。
  • 人型支原体宫颈阴道检出与早产及低出生体重显著相关。
  • 现有证据不推荐对孕妇常规筛查或治疗生殖支原体。

核心结论

  • 生殖支原体与不良妊娠结局的关联不限于羊膜腔内存在,宫颈阴道检测亦可见关联。
  • 鉴于观察性数据及残余混杂,这些关联需谨慎解读,不支持常规筛查或治疗。
  • 宫颈阴道检测应置于阴道微生物环境整体背景中解读,而非孤立病原效应证据。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase和Cochrane Library截至2026年2月1日的观察性研究。
  • 从11,957条记录中纳入156项研究进行荟萃分析。
  • 由四名评审独立筛选文献并提取数据,计算汇总比值比和均数差及95%置信区间。

主要发现

  • 排除羊水和胎盘标本的敏感性分析中,宫颈阴道样本与自发性早产和低出生体重的显著关联仍存在。
  • 宫颈阴道微小脲原体检出与早产显著相关(OR 1.63,95%CI 1.36-1.96)。
  • 脲原体属宫颈阴道检出与低出生体重(OR 1.56,95%CI 1.33-1.83)和小于胎龄儿(OR 1.47,95%CI 1.19-1.80)相关。
  • 人型支原体宫颈阴道样本检出与早产(aOR 1.75,95%CI 1.21-2.53)和低出生体重(OR 1.81,95%CI 1.51-2.16)显著相关。
  • 脲原体属妊娠早期检出相比妊娠中期阳性与早产的关联更强(P=.044)。

临床怎么用

  • 临床不应基于现有证据对孕妇常规筛查或治疗生殖支原体。
  • 宫颈阴道生殖支原体检出结果应结合阴道微生态整体评估解读。

局限性

  • 纳入研究均为观察性设计,存在残余混杂。
  • 关联结果需谨慎解读,不能推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Genital mycoplasmas (Mycoplasma genitalium, Mycoplasma hominis, and Ureaplasma species) are highly prevalent in women of reproductive age worldwide. The relevance of cervicovaginal detection in pregnancy remains controversial. This study aimed to assess their associations with adverse pregnancy outcomes. DATA SOURCES: We conducted a systematic review and meta-analysis of observational studies published up to February 1, 2026, in MEDLINE, Embase, and the Cochrane Library. STUDY ELIGIBILITY CRITERIA: Eligible studies reported the presence of any genital mycoplasmas and at least one adverse pregnancy outcome. STUDY APPRAISAL AND SYNTHESIS METHODS: Four reviewers independently selected studies and extracted data. Pooled odds ratios and mean differences with 95% confidence intervals were calculated. Univariate and subgroup analyses were performed for primary and secondary outcomes and multivariate analysis for preterm birth. Sensitivity analyses restricted to cohort studies and cervicovaginal sampling were conducted. RESULTS: Of 11,957 records, 156 studies were included in meta-analysis. In sensitivity analyses excluding amniotic fluid and placental specimens, significant associations with spontaneous preterm birth and low birthweight remained for cervicovaginal samples. Cervicovaginal detection of Ureaplasma parvum was significantly associated with preterm birth (odds ratio, 1.63; confidence interval, 1.36-1.96). For Ureaplasma species, first-trimester detection showed stronger associations compared to second-trimester positivity (P=.044). Cervicovaginal Ureaplasma detection was also associated with low birthweight (odds ratio, 1.56; confidence interval, 1.33-1.83) and small for gestational age (odds ratio, 1.47; confidence interval, 1.19-1.80). Mycoplasma hominis showed significant associations with both preterm birth (adjusted odds ratio, 1.75; confidence interval, 1.21-2.53) and low birthweight (odds ratio, 1.81; confidence interval, 1.51-2.16) when detected in cervicovaginal samples. CONCLUSION: Associations between genital mycoplasmas and adverse pregnancy outcomes are not limited to intra-amniotic presence but are also observed with cervicovaginal detection. Given the observational nature of the available data and residual confounding, these associations should be interpreted cautiously and do not support routine screening or treatment. Cervicovaginal detection should be interpreted within the broader context of the vaginal microbial environment rather than as evidence of an isolated pathogenic effect.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Fehér B, Amorim das Virgens IP, Bakony M, et al. Cervicovaginal detection of genital mycoplasmas is associated with preterm birth and low birth weight: a systematic review and multivariate meta-analysis of adverse pregnancy outcomes. Am J Obstet Gynecol. 2026. PMID: 41895366. doi:10.1016/j.ajog.2026.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。